
Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Thousands of genomes reveal the wild wolf genes in most dogs’ DNA - 2
Uranus's small moons are dark, red, and water-poor - 3
10 Hints and Deceives to Expand Cell Phone Information Use: Capitalize on Your Information - 4
Watch interstellar comet 3I/ATLAS make its closest approach to Earth in free livestream on Dec. 18 - 5
23 Most Amusing Messages At any point Sent Among Youngsters and Their Folks
Arctic is again the hottest it's been in 125 years, with record-low sea ice, NOAA report says
Step by step instructions to Guarantee Your Internet Promoting Degree Supplements Your Profession Objectives
ONE returns to Red Sea with new service
4 Creative Savvy Home Gadgets of 2024: Reforming Home Robotization and Security
Unusual 'ingredients' helped stars form in a galaxy near the Milky Way
Best Quest for new employment Site for You to Track down Amazing open doors
If someone's always late, is it time blindness, or are they just being rude?
Most loved Fish Dish: What's Your Sea Pleasure?
The most effective method to Help a Friend or family member Determined to have Cellular breakdown in the lungs













